P
2019
The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.
Report Code : A00381 | Pages : 261 | Category : Life Sciences
P
2021
The global cancer immunotherapy market size was valued at $85,603.50 million in 2020, and is projected to reach $309,667.65 million by 2030, registering a CAGR of 14.1% from 2021 to 2030.
Report Code : A01913 | Pages : 207 | Category : Life Sciences
P
2020
The cancer biomarkers market was valued at $10,944.08 million in 2019, and is projected to reach $26,979.50 million by 2027, registering a CAGR of 11.8% from 2020 to 2027.Cancer biomarkers are traceable substances or molecules that indicate the existence of cancerous cells in the body.
Report Code : A01124 | Pages : 338 | Category : Life Sciences
P
2021
The global cancer pain market was valued at $6,197.8 million in 2020, and is estimated to reach $10,329.4 million by 2030, growing at a CAGR of 5.3% from 2021 to 2030.
Report Code : A04761 | Pages : 189 | Category : Life Sciences
P
2022
The global cancer gene therapy market was valued at $1.4 billion in 2020, and is projected to reach $11.4 billion by 2030, growing at a CAGR of 23.3% from 2021 to 2030.
Report Code : A02273 | Pages : 186 | Category : Life Sciences
P
2020
The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.
Report Code : A01134 | Pages : 284 | Category : Life Sciences
P
2024
The global cancer supportive care drugs market was valued at $20.4 billion in 2022, and is projected to reach $25 billion by 2032, growing at a CAGR of 2% from 2023 to 2032.
Report Code : A07133 | Pages : 338 | Category : Life Sciences
P
2022
The global cancer stem cells market was valued at $1.1 billion in 2021 and is projected to reach $2.7 billion by 2031, growing at a CAGR of 10% from 2022 to 2031.
Report Code : A08105 | Pages : 200 | Category : Life Sciences
U
2024
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is a result multiple factors, due to a complex interaction of tumor and host factors.
Report Code : A08106 | Category : Life Sciences
U
2024
Cancer patient registry software is a computerized database that is used for the organization, collection, and storing of the data of all the cancer patients for the evaluation of cancer-specific results, drug or medical device exposure, and conditions.
Report Code : A10261 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.